Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

02-07

Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances

In the era of the generative economy,Medidata is transforming how industries are empowering patients with new cure and care experiences and lifelong engagement

02-07

TRILLER PUTS CREATORS FIRST AS IT UNLEASHES THE FUTURE OF TECH, MUSIC & CULTURE WITH THE LATEST VERSION OF ITS APP

Powered by next-generation technology and with data privacy front and center,Triller is redefining the creator economy with new ways for brands and creators to own their content,connect with their fa

02-07

Modlily Unveils SS25 Flattering and Supportive Tummy Coverage Swimsuits Collection--Perfct Choices for Older Women

LOS ANGELES,Feb. 6,2025--Looking for a swimsuit that\'s both supportive and flattering? Modlily is excited to introduce its SS25 tummy coverage collection.

02-07

Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

HONG KONG,Feb. 6,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company")is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/

02-07

Foretellix and MathWorks Partner on Innovative Toolchain to Accelerate Mazda's Next Generation AV Development

TOKYO and SUNNYVALE,Calif.,Feb. 6,2025-- Strategic technological integration between Foretellix,the leading provider of data-driven autonomy development toolchains,and MathWorks,the leading developer

02-07

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

PERTH,Australia,Feb. 6,2025-- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF),a clinical-stage biopharmaceutical company brings hope to epilepsy patients.

02-07

GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC

GCCL is committed to customer success,emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research an

02-07

Dubai Fountain Undergoes a Stunning Revamp: Temporary Closure Announced for Upgrade and Enhancement

Starting in May,the iconic attraction will be closed for five months DUBAI,UAE,Feb. 6,2025-- Emaar has announced the temporary closure of Dubai Fountain,the world\'s largest performing fountain,locate

02-07

Global Africa Business Initiative Calls for a Bold Reimagining of Africa's Economic Narrative

NEW YORK,Feb. 6,2025-- The Global Africa Business Initiative (GABI) issued its Unstoppable Africa 2024 Executive Summary today,shedding light on transformative strategies and solutions to reshape Afr

02-07